Granules India gets FDA approval for generic epilepsy drug Levetiracetam
Granules India has announced its receipt of approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets USP, in 250 mg, 500 mg, 750 mg, and 1,000 mg strengths. The drug, bioequivalent and therapeutically equivalent to UCB, Inc.’s reference listed drug (RLD), Keppra Tablets, is used […]